|
|
||||||||
1Department of Medicine, University of Adelaide, Royal Adelaide Hospital, Adelaide, South Australia, Australia; and 2Division of Investigative Science, Imperial College London at Hammersmith Campus, London, United Kingdom
Submitted 13 May 2005 ; accepted in final form 1 July 2005
Stimulation of cholecystokinin and glucagon-like peptide-1 secretion by fat is mediated by the products of fat digestion. Ghrelin, peptide YY (PYY), and pancreatic polypeptide (PP) appear to play an important role in appetite regulation, and their release is modulated by food ingestion, including fat. It is unknown whether fat digestion is a prerequisite for their suppression (ghrelin) or release (PYY, PP). Moreover, it is not known whether small intestinal exposure to fat is sufficient to suppress ghrelin secretion. Our study aimed to resolve these issues. Sixteen healthy young males received, on two separate occasions, 120-min intraduodenal infusions of a long-chain triglyceride emulsion (2.8 kcal/min) 1) without (condition FAT) or 2) with (FAT-THL) 120 mg of tetrahydrolipstatin (THL, lipase inhibitor), followed by a standard buffet-style meal. Blood samples for ghrelin, PYY, and PP were taken throughout. FAT infusion was associated with a marked, and progressive, suppression of plasma ghrelin from t = 60 min (P < 0.001) and stimulation of PYY from t = 30 min (P < 0.01). FAT infusion also stimulated plasma PP (P
0.01), and the release was immediate. FAT-THL completely abolished the FAT-induced changes in ghrelin, PYY, and PP. In response to the meal, plasma ghrelin was further suppressed, and PYY and PP stimulated, during both FAT and FAT-THL infusions. In conclusion, in healthy humans, 1) the presence of fat in the small intestine suppresses ghrelin secretion, and 2) fat-induced suppression of ghrelin and stimulation of PYY and PP is dependent on fat digestion.
lipase inhibition; gut hormone secretion
This article has been cited by other articles:
![]() |
K. L Feltrin, T. J Little, J. H Meyer, M. Horowitz, T. Rades, J. Wishart, and C. Feinle-Bisset Comparative effects of intraduodenal infusions of lauric and oleic acids on antropyloroduodenal motility, plasma cholecystokinin and peptide YY, appetite, and energy intake in healthy men Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1181 - 1187. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Roche, A. J. Sheahan, L. M. Chagas, and R. C. Boston Short Communication: Change in Plasma Ghrelin in Dairy Cows Following an Intravenous Glucose Challenge J Dairy Sci, March 1, 2008; 91(3): 1005 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D'Silva, X. Xiao, and M. E. Lowe A polymorphism in the gene encoding procolipase produces a colipase, Arg92Cys, with decreased function against long-chain triglycerides J. Lipid Res., November 1, 2007; 48(11): 2478 - 2484. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J Little, M. Horowitz, and C. Feinle-Bisset Modulation by high-fat diets of gastrointestinal function and hormones associated with the regulation of energy intake: implications for the pathophysiology of obesity Am. J. Clinical Nutrition, September 1, 2007; 86(3): 531 - 541. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Germain, B. Galusca, C. W Le Roux, C. Bossu, M. A Ghatei, F. Lang, S. R Bloom, and B. Estour Constitutional thinness and lean anorexia nervosa display opposite concentrations of peptide YY, glucagon-like peptide 1, ghrelin, and leptin Am. J. Clinical Nutrition, April 1, 2007; 85(4): 967 - 971. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Degen, J. Drewe, F. Piccoli, K. Grani, S. Oesch, R. Bunea, M. D'Amato, and C. Beglinger Effect of CCK-1 receptor blockade on ghrelin and PYY secretion in men Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1391 - R1399. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |